Immune Thrombocytopenia-A Neglected Adverse Event of PD-1 and PD-L1 Inhibitors in Clinical Trials-MedSci.cn

Immune Thrombocytopenia-A Neglected Adverse Event of PD-1 and PD-L1 Inhibitors in Clinical Trials

Pang, XC; Su, X; Cui, YM

Cui, YM (reprint author), Peking Univ, Dept Pharm, Hosp 1, 8 Xishiku St, Beijing 100034, Peoples R China.

JAMA ONCOLOGY, 2019; 5 (11): 1640